Stay updated on KSI-301 vs Aflibercept in Wet AMD Clinical Trial
Sign up to get notified when there's something new on the KSI-301 vs Aflibercept in Wet AMD Clinical Trial page.

Latest updates to the KSI-301 vs Aflibercept in Wet AMD Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedCore content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior v3.1.0 tag was removed.SummaryDifference3%

- Check30 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.1%

- Check37 days agoChange DetectedAdded a new topic/section titled “Eye Care,” expanding the page’s scope. No deletions were made.SummaryDifference0.8%

- Check44 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the Back to Top element was removed, with no other substantive content changes detected.SummaryDifference0.2%

- Check51 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check59 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations, as well as expanded information on various eye diseases and conditions. Notably, the revision number has been updated to v3.0.0.SummaryDifference4%

Stay in the know with updates to KSI-301 vs Aflibercept in Wet AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KSI-301 vs Aflibercept in Wet AMD Clinical Trial page.